Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 98

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 98
---
i) no later than the second business day following the satisfaction or waiver of the conditions described below under the section titled “ Conditions to the Consummation of the Merger” on page 158 of this proxy statement/prospectus, or (ii) on such other date as agreed to by the parties to the Merger Agreement in writing, in each case, subject to the satisfaction or waiver of the closing conditions. The Merger Agreement may be terminated by NLS and/or Kadimastem if the Closing has not occurred by August 31, 2025. NLS and Kadimastem anticipate that the consummation of the Merger will occur in the third quarter of 2025. However, because the Merger is subject to a number of conditions, neither NLS nor Kadimastem can predict exactly when the Closing will occur or if it will occur at all. For a description of the conditions to the completion of the Merger, see the section titled “ Conditions to the Consummation of the Merger” on page 158 of this proxy statement/prospectus. NLS Meeting (Page 104) Date, Time and Place of the of the NLS Meeting The NLS Meeting will be held at 4:00 pm, local time, on August 21, 2025, at the premises of Baker McKenzie Switzerland AG, Holbeinstrasse30, 8034 Zurich, Switzerland. NLS will be hosting the NLS Meeting in person to consider and vote upon: •Proposal No. 1 to approve the Merger Agreement. •Proposal No. 2 to approve the par value reduction, reverse split and ordinary share capital increase with contribution of the Kadimastem shares to implement the Merger. •Proposal No. 3 to approve the ordinary share capital increase regarding the issuance of NLS Preferred Shares. •Proposal No. 4 to approve the reinstatement of the capital band. •Proposal No. 5 to approve the conditional share capital for employee and advisory options. •Proposal No. 6 to approve the conditional share capital for shareholders’ options. •Proposal No. 7 to approve the transfer and voting rights limitation of 9.99%. •Proposal No. 8 to approve the name change of NLS. •Proposal No. 9 to approve the election of the new members to the NLS Board. •Proposal No. 10 to approve the election of members of the Compensation, Nomination and Governance Committee. •Proposal No. 11